Literature DB >> 32556132

A master erythroid regulator gets its own GPS.

Lily Jun-Shen Huang1, James J Bieker2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32556132      PMCID： PMC7316213          DOI： 10.1182/blood.2020005882

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Structural characterization of a noncovalent complex between ubiquitin and the transactivation domain of the erythroid-specific factor EKLF.

Authors:  Luca Raiola; Mathieu Lussier-Price; David Gagnon; Julien Lafrance-Vanasse; Xavier Mascle; Genevieve Arseneault; Pascale Legault; Jacques Archambault; James G Omichinski
Journal:  Structure       Date:  2013-10-17       Impact factor: 5.006

Review 2.  Orchestration of late events in erythropoiesis by KLF1/EKLF.

Authors:  Merlin Nithya Gnanapragasam; James J Bieker
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

Review 3.  Eukaryotic transcription factors: paradigms of protein intrinsic disorder.

Authors:  Lasse Staby; Charlotte O'Shea; Martin Willemoës; Frederik Theisen; Birthe B Kragelund; Karen Skriver
Journal:  Biochem J       Date:  2017-07-12       Impact factor: 3.857

4.  GPS2 promotes erythroid differentiation by control of the stability of EKLF protein.

Authors:  Wen-Bing Ma; Xiao-Han Wang; Chang-Yan Li; Huan-Huan Tian; Jie Zhang; Jun-Jie Bi; Guang-Ming Ren; Shou-Song Tao; Xian Liu; Wen Zhang; Dong-Xu Li; Hui Chen; Yi-Qun Zhan; Miao Yu; Chang-Hui Ge; Xiao-Ming Yang; Rong-Hua Yin
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

5.  G protein pathway suppressor 2 (GPS2) links inflammation and cholesterol efflux by controlling lipopolysaccharide-induced ATP-binding cassette transporter A1 expression in macrophages.

Authors:  Zhiqiang Huang; Ning Liang; Anastasius Damdimopoulos; Rongrong Fan; Eckardt Treuter
Journal:  FASEB J       Date:  2018-08-28       Impact factor: 5.191

6.  Inhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development.

Authors:  Claudia Lentucci; Anna C Belkina; Carly T Cederquist; Michelle Chan; Holly E Johnson; Sherry Prasad; Amanda Lopacinski; Barbara S Nikolajczyk; Stefano Monti; Jennifer Snyder-Cappione; Bogdan Tanasa; M Dafne Cardamone; Valentina Perissi
Journal:  J Biol Chem       Date:  2016-12-30       Impact factor: 5.157

Review 7.  EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.

Authors:  Yvette Y Yien; James J Bieker
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

Review 8.  Ubiquitin-independent proteasomal degradation.

Authors:  Jenny Erales; Philip Coffino
Journal:  Biochim Biophys Acta       Date:  2013-05-14

9.  Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN.

Authors:  Quinlan L Sievers; Georg Petzold; Richard D Bunker; Aline Renneville; Mikołaj Słabicki; Brian J Liddicoat; Wassim Abdulrahman; Tarjei Mikkelsen; Benjamin L Ebert; Nicolas H Thomä
Journal:  Science       Date:  2018-11-02       Impact factor: 47.728

Review 10.  Krüppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants.

Authors:  Andrew Perkins; Xiangmin Xu; Douglas R Higgs; George P Patrinos; Lionel Arnaud; James J Bieker; Sjaak Philipsen
Journal:  Blood       Date:  2016-02-22       Impact factor: 22.113
  10 in total
  1 in total

Review 1.  Differentiation of human induced pluripotent stem cells into erythroid cells.

Authors:  Mohsen Ebrahimi; Mehdi Forouzesh; Setareh Raoufi; Mohammad Ramazii; Farhoodeh Ghaedrahmati; Maryam Farzaneh
Journal:  Stem Cell Res Ther       Date:  2020-11-16       Impact factor: 6.832
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.